Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Hypothesis

Stone age diseases and modern AIDS

Author: Arthur L Koch

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

The great advantage of being a sexually transmitted disease is the ability to survive and specialize solely on a host species that is present in low numbers and widely distributed so that contact between infected and uninfected organisms by chance is rare.
Pathogens of a sparse, but widely distributed host species, must either: i) have an alternative host; ii) be able to survive in a dormant state; or iii) be non-destructive to their host. For the pathogens of a diploid there is a particularly effective strategy, that of being sexually transmitted. Then the hosts' themselves transfer the pathogen.
Literature
1.
Hoeprich PD, Jordan MC, Ronald RA, et al.: Infectious diseases: a treatise of infectious processes. 5th edition. Philadelphia, Lippincott; 1994.
2.
Gilbert GL: Infectious diseases: challenges for the 1990s. Philadelphia: Bailliere Tindall; 1993.
3.
Roizman B, editor: Infectious diseases in an age of change: the impact of human ecology and behavior on disease transmission. Washington: National Academy Press; 1995.
4.
Mandell GL, Bennett JE, Dolin R: Principles and practice of infectious disease. Forth edition. New York: Churchill Lenigton; 1995.
5.
White DO, Fenner FJ: Medical Virology. 4th edition. San Diego: Academic press; 1994.
6.
Quinn TC: Sexually transmitted diseases. Bethesda, MD: Clinical Center, National Institutes of Health, Bethesda; 1993.
7.
Broder S, Merrigan TC, Bolognesi D: Textbook of AIDS Medicine. Williams and Wilkins, Baltimore; 1994.
8.
Hahn BH: Viral genes and their products. In Textbook of AIDS Medicine. Edited by: Broder S, Merrigan TC, Bolognesi D. Baltimore: Williams and Wilkins; 1994:21-39.
9.
Levy JA: HIV and the Pathogenesis of AIDS. third edition. ASM Press; 2007.
10.
Wrangham RW: An ecological model of female-bonded primate groups. Behaviour 1980, 75: 262-299. 10.1163/156853980X00447CrossRef
11.
Nishida T: The social structure of chimpanzees of the Mahale Mountains. In The great apes. Edited by: Hamburg DA, McCown ER. Benjamin Cummings, Menlo Park; 1979:73-121.
12.
Manson JH, Perry SE: Inbreeding avoidance in rhesus macaques: Whose choice? Amer J of Physical Anthro 1993, 90: 335-344. 10.1002/ajpa.1330900307CrossRef
13.
Packer C: Inter-troop transfer and inbreeding avoidance in Papio Anubis. Animal Behavior 1979, 27: 1-36. 10.1016/0003-3472(79)90126-XCrossRef
14.
Pusey AE, Packer C: Dispersal and philopatry. In Primate societies. Edited by: Smuts BB, Cheney DL, Seyfarth RM, Wrangham RM, Struhsaker TT. Chicago: University of Chicago Press; 1987:250-26.
15.
Mendel GL, Reined MF, et al.: Sexually transmitted diseases. Current Medicine, Philadelphia; 1996.
16.
Broder S, Merrigan TC, Bolognesi D: Textbook of AIDS Medicine. Williams and Wilkins, Baltimore; 1994.
17.
Habtom H, de Beer C, Lotz ZE, Tyler MG, Schoeman L, Kahn D, Mall AS: The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay. Virology Journal 2008, 5: 59. 10.1186/1743-422X-5-59CrossRef
18.
Kurth R, Norley S: Simian Immunodeficiency viruses of African green monkeys. In Simian immunodeficiency viruses. Edited by: Letving NL, Dessosiers R. Berlin-Heidelberg: Springer-Verlag; 1994:21-33.CrossRef
19.
Eigen M, Nieselt-Struwe K: How old is the immunodeficiency virus? AIDS 1990, 4: S85-S93. 10.1097/00002030-199001001-00014CrossRefPubMed
20.
Reines BP: Radiation, chimpanzees, and the origin. Perspectives in Biology and Medicine 1996,39(2):187-192.CrossRefPubMed
21.
Ewald PW: Evolution of infectious disease. Oxford: Oxford University Press; 1994.
22.
Russell MW, Lue D, Bake AW, Moldoveanu Z, Mestecky J: Molecular heterogeneity of human IgA antibodies during an immune response. Clinical Experimental Immunology 1992,87(1):1-6.PubMedCentralCrossRefPubMed
23.
Lehner T, Bergmeir LA, Panagiotidi T, et al.: Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992, 258: 1365-1369. 10.1126/science.1360702CrossRefPubMed
24.
Morrow CD, Porter DC, Ansardi Z, Moldoveanu Z, Fultz PN: New approaches for mucosal vaccines for AIDS: Encapsidation and serial passage of poliovirus replicons that express HIV-1 proteins on infection. AIDS research and human retroviruses 1994, 10: S61-S66.CrossRefPubMed
25.
Mestecky J, Kutteh WH, Jackson S: Mucosal Immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res Hum Retroviruses 1994, 10: S11-S20.PubMed
26.
Kutteh WH, Mestecky J: Secretory immunity in the female reproductive tract. American Journal Reproductive Immunology 1994, 31: 40-46.CrossRef
27.
Lohman BL, McChesney MB, Miller CJ, Otsyula M, Berardi CJ, Marthas ML: Mucosal immunization with live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques. J Med Primatol 1994,23(2-3):95-101.CrossRefPubMed
28.
Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM: Pathogenicity of live, attenuated SIV after mucosal infection of neonate macaques. Science 1995, 267: 1820-1825. 10.1126/science.7892606CrossRefPubMed
29.
Dunn DT, Brandt CD, Krivinet A, Cassol SA, Roques PS, Borkowsky WP, Rossi AD, Denamur E, Ehrnst A, Loveday C, Harris J-A, McIntosh K: The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995, 9: F7-F11. 10.1097/00002030-199509000-00001CrossRefPubMed
30.
Quesada-Rolander MB, Mäkitalo R, Thorstensson Y-J, Zhang E, Castaños-Velez E, Biberfeld G, Putkonen P: Protection against mucosal SIV challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Research and Human Retroviruses 1996, 12: 993-999.CrossRefPubMed
31.
Overbaugh J, Anderson RJ, Ndinya-Achola JO, Kreiss JK: Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Res Hum Retroviruses 1996,12(2):107-115.CrossRefPubMed
32.
Edwards RP, Pitt A, Crowley-Nowick P, Partridge EE, Gore H, Mestecky J: Immunoglobulin-containing plasma cells recruited to cervical neoplasia. Obstetrics Gynecol 1996, 87: 520-526. 10.1016/0029-7844(95)00454-8CrossRef
33.
Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, Michalek SM: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and cholera toxin B subunit. Infection Immunity 1996, 64: 1273-283.
34.
Van Rompay KK, Otsyula MG, Tarara RP, Canfield DR, Berardi CJ, McChesney MB, Marthas ML: Vaccination of pregnant macaques protects newborn against mucosal simian immunodeficiency virus infection. J Infect Dis 1996, 173: 1327-1335.CrossRefPubMed
35.
Brandzaeg P: Mucosal immunity in the female genital tract. J Reproductive Immunology 1997, 36: 23-50. 10.1016/S0165-0378(97)00061-2CrossRef
36.
Brandzaeg P, Johansen F-E: Mucosal B cells: phenotypic characteristics, transcriptional regulation and homing properties. Immunological Rev 2005, 206: 32-63. 10.1111/j.0105-2896.2005.00283.xCrossRef
37.
Holmgren J, Czerkinsky C: Mucosal immunity and vaccines. Nature Medicine 2005. doi: 10:1038/nm1213
38.
Kaiserlian D, Cerf-Bensussan N, Hosmalin AJ: The mucosal immune system: from control of inflammation to protection against infections. Leukoc Biology 2005, 78: 311-318. 10.1189/jlb.0105053CrossRef
39.
Mestecky J, Moldoveanu Z, Russell MW, et al.: Immunologic Uniqueness of the genital tract: Challenge for vaccine development. Amer J Reproductive Immunology 2005, 53: 208-214. 10.1111/j.1600-0897.2005.00267.xCrossRef
40.
Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L: Innate and adaptive immunity in female genital tract: Cellular response and interactions. Immunological Reviews 2005, 206: 306-335. 10.1111/j.0105-2896.2005.00287.xCrossRefPubMed
41.
McWhinney S, Pagano M, Thomas P: Age at AIDS: diagnosis for children with perinatally acquired HIV. Journal of Acquired Immune Deficiency Syndromes 1993, 6: 1139-1144.
42.
Arold ST, Baur AS: Dynamic nef and nef dynamics, how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 2001, 26: 356-363. 10.1016/S0968-0004(01)01846-1CrossRefPubMed
43.
Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T: Human β-defensin-1: An antimicrobial peptide of urogenital tissues. J Clinical Invest 1988, 101: 1633-1642. 10.1172/JCI1861CrossRef
44.
Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, Waring AJ, Kaznessis Y, Lu W, Bradley KA, Lehrer RL: Retrocyclins kill bacillus and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 2006, 281: 32755-32764. 10.1074/jbc.M603614200PubMedCentralCrossRefPubMed
45.
Wang Q, Wang W, Zheng J, Tabibian S, Xie Y, Song J, Waring AJ, Chiu R, Yang OO, Chen IS, Lehrer RI, Pang S: Paradoxical effects of two Theta-Defensins on HIV type 1 infection. AIDS research and human retroviruses 2007, 23: 508-514. 10.1089/aid.2006.0119CrossRefPubMed
46.
Bosire R, John-Stewart GC, Mabuka JM, Wariua G, Gichuhi C, Wamalwa D, Ruzinski J, Goodman R, Lohman B, Mbori-Ngacha DA, Overbaugh J, Farquhar C: Breast milk α-Defensins are associated with HIV Type 1 RNA and CC chemokines in breast milk but not vertical HIV Type 1 transmission. AIDS research and human retroviruses 2007, 23: 198-203. 10.1089/aid.2006.0125PubMedCentralCrossRefPubMed
47.
Quiñones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A: Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003, 17: F39-F48. 10.1097/00002030-200311070-00001CrossRefPubMed
48.
MasCasullo VE, Fam MJ, Keller , Herold BC: Role of mucosal immunity in preventing genital Herpes infection. Viral Immun 2005, 18: 595-606. 10.1089/vim.2005.18.595CrossRef
49.
Wahl SM, Worley P, Jin W, McNeely TB, Eisenberg S, Fasching C, Orenstein JM, Janoff EN: Anatomic dissociation between HIV1 and its endogenous inhibitor in mucosal tissues. American Journal of Pathology 1997, 150: 1275-1284.PubMedCentralPubMed
50.
Esquerré M, Tauzin B, Guiraud M, Müller S, Saoudi A, Valitutti S: Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-beta-dependent mechanism. Proc Natl Acad Sci USA 2008, 105: 2550-2555. 10.1073/pnas.0708350105PubMedCentralCrossRefPubMed
51.
Walker MC, Walker BD, Mestecky J, Mathieson BJ: Conference on advances in AIDS vaccine development – 1993, Summary: cytotoxic T-cell immunity workshop. AIDS Research and human retroviruses 1994, 10: S177-S179.PubMed
52.
Chirmule N, Lesser M, Gupta A, Ravipati M, Kohn N, Pahwa S: Immunological characteristics of HIV-infected children: Relationship to age, CD4 counts, disease progression, and survival. AIDS Res Hum Retroviruses 1995,11(10):1209-1219.CrossRefPubMed
53.
Rabin RL, Roederer M, Maldonado V, Petu A, Herzenberg LA: Altered representation of naive and memory CD* T cells subsets in HIV-infected children. J Clinical Investigation 1995, 95: 2053-2069.CrossRef
54.
Miedema F, Klein MR: AIDS pathogenesis: A finite immune response to blame? Science 1996, 272: 505-506. 10.1126/science.272.5261.505CrossRefPubMed
55.
Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT: Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1966, 272: 537-542. 10.1126/science.272.5261.537CrossRef
56.
Darby SC, Ewart DW, Giangrande PLF, et al.: Mortality before and after HIV infection in the complete UK population of haemophiliacs. Nature 1995, 377: 79-82. 10.1038/377079a0CrossRefPubMed
57.
Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373: 123-126. 10.1038/373123a0CrossRefPubMed
58.
Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373: 117-122. 10.1038/373117a0CrossRefPubMed
59.
Pang S, Su D, An DS, Baldwin GC, Xie Y, Poon B, Chow YH, Park NH, Chen ISY: Human immunodeficiency virus env -independent infection of human CD4(-) cells. J Virol 74: 10994-11000. 10.1128/JVI.74.23.10994-11000.2000
60.
61.
Mitler J, Antia R, Levin B: Population dynamics of HIV pathogenesis. Trends Ecology Evolution 10: 224-227. 10.1016/S0169-5347(00)89069-2
62.
Diaz RS, Sabino EC, Mayer A, de Oliveira CF, Mossley JW, Busch MP: Lack of dual HIV infection in a transfusion recipient exposed to two seropositive blood components. AIDS Res Hum Retroviruses 1996,12(13):1291-1295.CrossRefPubMed
63.
Pizzo PA, Wilfert CM: Pediatric AIDS. Second edition. Baltimore: William and Wilkins; 1994.
64.
Remington JS, Klein JO, (editors): Infectious diseases of the fetus and newborn infant. 4th edition. Philadelphia: Saunders; 1995.
65.
Sweet RL, Gibbs RS: Infectious diseases of the female genital tract. 3rd edition. Baltimore: Williams and Wilkins; 1995.
66.
Kaschula ROC: AIDS. In Paediatric pathology. Third edition. Edited by: Berry CL. Springer Verlag, Berlin; 1996:821-835.CrossRef
67.
Clerici M, Sison AV, Berzofsky JA, Rakusan TA, Brandt CD, Ellaurie M, Villa M, Colie C, Venzon DJ, Sever JL, et al.: Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993, 7: 1427-1433.CrossRefPubMed
68.
Roques PA, Gras G, Parnet-Mathieu F, et al.: Clearance of HIV in 12 perinatal infected children: clinical, virological and immunological data. AIDS 1995, 9: F19-F26.CrossRefPubMed
69.
Scott GS: Special considerations in children. In Textbook of AIDS Medicine. Edited by: Broder S, Merrigan TC, Bolognesi D. Williams and Wilkins, Baltimore; 1994:169-181.
70.
Cotton DJ: AIDS in Women. In Textbook of AIDS Medicine. Edited by: Broder S, Merrigan TC, Bolognesi D. Williams and Wilkins, Baltimore; 1994:161-168.
71.
Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. New England Journal of Medicine 1994, 331: 1173-1180. 10.1056/NEJM199411033311801CrossRefPubMed
72.
Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM: A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advance human immunodeficiency virus infection. New England Journal of Medicine 1994, 331: 1181-1187. 10.1056/NEJM199411033311802CrossRefPubMed
73.
Rouse DJ, Owen OJ, Goldenberg RL, Vermund SH: Zidovudine for the prevention of vertical HIV transmission: a decision analytical approach. Journal Acquired Immune Deficiency Syndrome Human Retroviruses 1995, 9: 401-407.
74.
Brossard Y, Aubin JT, Mandelbrot L, Bignozzi C, et al.: Frequency of early in-utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995, 9: 359-366.CrossRefPubMed
75.
Bryson YJ: HIV clearance in infants – a continuing saga. AIDS 1995, 9: 1373-1375. 10.1097/00002030-199512000-00011CrossRefPubMed
76.
Anderson RM, May RM: Infectious diseases of humans: dynamics and control. New York: Oxford University Press; 1991.
77.
Höllsberg P, Hafler DA: Human T-cell lymphotropic virus type I. Chichester; John Wiley and Sons; 1996.
78.
Wiktor SZ, Blattner WA: Epidemiology of human T-cell leukemia virus type I (HTLV-I). In The human retroviruses. Edited by: Gallo RC, Jay G. San Diego: Academic Press; 1991:175-192.CrossRef
79.
Blattner WA: Human T lymphotrophic viruses: HTLV-I and HTLV-II. 1994.
80.
Yoshida M, Inoue J-I, Fujisawa JI: Positive and negative regulation of human T cell leukemia virus type I (HTLV-I) gene expression and replication: function of the rex gene. In The human retroviruses. Edited by: Gallo RC, Jay G. San Diego: Academic Press; 1991:3-20.CrossRef
81.
Hinrichs SH, Chen L-S, Fontes J, Jay G: Human T-cell Leukemia virus type I (HTLV-I): Studies of disease mechanism in a transgenic mouse system. In The human retroviruses. Edited by: Gallo RC, Jay G. San Diego. Academic Press; 1991:225-243.
82.
Daniel MD, Kirchoff F, Czajak PK, Schgal PK, Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258: 1938-1941. 10.1126/science.1470917CrossRefPubMed
83.
Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip WA, Chen ISY: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral. Cell 1990, 61: 213-222. 10.1016/0092-8674(90)90802-LCrossRefPubMed
84.
Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA: HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO Journal 1990, 9: 1551-1560.PubMedCentralPubMed
85.
Haase AT: Perils at mucosal front lines: For HIV and SIV and their hosts. Nat Rev Immunology 2005, 5: 783-792.CrossRefPubMed
86.
Metadata
Title
Stone age diseases and modern AIDS
Author
Arthur L Koch
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-93

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue

Research

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection

Research

The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor

Short report

Bioinformatic analysis suggests that the Cypovirus 1 major core protein cistron harbours an overlapping gene

Research

Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?

Research

Down-regulation of cell surface CXCR4 by HIV-1

Research

Herpes Simplex Virus Type 1 Us3 Gene Deletion Influences Toll-like Receptor Responses in Cultured Monocytic Cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits